Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of “Buy” from Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have earned an average rating of “Buy” from the sixteen brokerages that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $26.67.

A number of research analysts have recently weighed in on PRVA shares. Canaccord Genuity Group raised their price objective on Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. Piper Sandler raised their price target on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, February 28th. Stephens reaffirmed an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Needham & Company LLC reissued a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a report on Friday, March 21st. Finally, Macquarie initiated coverage on shares of Privia Health Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $22.59 on Monday. The firm has a market cap of $2.72 billion, a price-to-earnings ratio of 225.92, a P/E/G ratio of 3.47 and a beta of 0.85. The firm has a fifty day moving average price of $23.80 and a 200 day moving average price of $21.20. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $26.04.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds have recently added to or reduced their stakes in the company. Mackenzie Financial Corp boosted its position in shares of Privia Health Group by 87.2% during the fourth quarter. Mackenzie Financial Corp now owns 72,391 shares of the company’s stock valued at $1,415,000 after buying an additional 33,728 shares during the period. Neo Ivy Capital Management boosted its holdings in Privia Health Group by 81.5% during the 4th quarter. Neo Ivy Capital Management now owns 6,540 shares of the company’s stock valued at $127,000 after acquiring an additional 2,936 shares during the period. PharVision Advisers LLC bought a new position in Privia Health Group in the 4th quarter valued at $259,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Privia Health Group by 13.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 939,170 shares of the company’s stock worth $18,361,000 after purchasing an additional 114,647 shares during the period. Finally, Two Sigma Advisers LP bought a new stake in shares of Privia Health Group during the fourth quarter worth $940,000. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.